Aspirin inhibits highly invasive prostate cancer cells.

International journal of oncology

Volumn 23, Issue 5, 2003, Pages 1277-1283

  Lloyd Jr , Frank P ^a   Slivova, Veronika ^a   Valachovicova, Tatiana ^a   Sliva, Daniel ^a  

^a METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACTIN; ANTITHROMBOCYTIC AGENT; CHLORAMPHENICOL ACETYLTRANSFERASE; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UROKINASE; VERY LATE ACTIVATION ANTIGEN 3; VITRONECTIN;

ARTICLE; BIOLOGICAL MODEL; CANCER INVASION; CELL ADHESION; CELL MOTION; DOSE RESPONSE; GENETIC TRANSFECTION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; METASTASIS; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ACTINS; ASPIRIN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA3BETA1; MALE; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NF-KAPPA B; PLATELET AGGREGATION INHIBITORS; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TRANSFECTION; URINARY PLASMINOGEN ACTIVATOR; VITRONECTIN;

EID: 3142782442     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.23.5.1277     Document Type: Article

References (0)